ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNG Synairgen Plc

4.52
-0.235 (-4.94%)
24 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.235 -4.94% 4.52 4.35 4.69 4.75 4.36 4.75 212,429 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 5776 to 5797 of 99175 messages
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older
DateSubjectAuthorDiscuss
30/4/2020
14:48
Decent size volume still going through, surprised we haven't regained momentum after the spike down.Just a matter of time
cambradjones
30/4/2020
14:39
An interesting article in today's Guardian on treatments for Coronavirus:

"....But whether remdesivir works or not, there are still all those other possibilities on the horizon. The World Health Organization chose three other potential therapies in addition to remdesivir to back in its Solidarity trial, which is supporting patient studies all over the world. These are interferon beta-1a, a molecule that our immune system produces; lopinavir, an approved treatment for HIV; and chloroquine/hydroxychloroquine, malaria drugs which have caused controversy due to their side-effects (as well as for being touted by Donald Trump). It’s worth noting that lopinavir and the malaria drugs have also failed previous trials for Covid-19."

aquilla
30/4/2020
14:35
If they're going to post it, means its considered safe. But we knew anyway
bobaxe1
30/4/2020
14:34
From Twitter Worth looking at Dr. Tom Wilkinson (lead of #SNG #Synairgen trial) - he is now also clinical academic lead for the Uk Government's ACCORD (ACcelerating COVID-19 dRug Development)...I suspect no coincidence...southampton.ac.uk/news/2020/04/a...
slinkyj
30/4/2020
14:23
thwarnts. Yes thanks. Just wished I'd sold my remaining holdings in tern first thing this morning and put it in here.Wouldn't that have been a good move !!!!
cambradjones
30/4/2020
14:22
An FDA research article published yesterday looked at 19 potential treatments. Incidentally SNG was not looked at. And the result was that only Remdesivir stood out with potential. That leaves a fairly open goal for SNG even if it shows weak efficacy.



"Evaluation of 19 antiviral drugs against SARS-CoV-2 Infection"

The Home Treatment news is unique in the world of COVID treatments as far as I know and the story could be picked up worldwide.

I would be pleased to see Remdesivir approved since it sets out a roadmap for SNG to hopefully follow.

Interesting times.

pdt
30/4/2020
14:15
Would we be manufacturing SNG001 'IF' it was a no goer!!
bmnsa
30/4/2020
14:15
Over at TERN
vitec
30/4/2020
14:13
Where is mr Floyd Magic? Likya? Been a bit quiet, hope he's not out?
slinkyj
30/4/2020
14:12
Exactly V. This would have been shelved before suggesting home trials if things were not extremely positive. If lockdowns are going to be eased, this is right here ready to help with the herd immunity stage, and any other lung issues going forward.
slinkyj
30/4/2020
14:11
Wait to the media gets hold of this. It will get to the £1 purely on momentum buying. The difference is there is a real story here and it could potentially save millions of lives. That is the best story you can get and every man and his dog will want a piece of the action. Blimey, I am getting to sound like Likya/Wally!!
vitec
30/4/2020
14:09
What about 360 mentioned
bobaxe1
30/4/2020
14:08
I am assuming 'home' means nursing homes and even in that environment, it is not clear how you set up and monitor a double blind trial.

Very odd indeed - that latest change to SNG016 does not make sense to me.

toffeeman
30/4/2020
14:07
Any outcome from 1 in 2 surviving ICU has to be good. This is more when then if for me that this will work. The evidence is mounting.
vitec
30/4/2020
14:06
Lets hope so and keep buying on any pullback.
bmnsa
30/4/2020
14:03
Also big pharmas are fishing for bios showing promise. Been some noise about that today. No one wants to be out the game and SNG are at the top of it right now. The world needs a great treatment otherwise people will be to scared to go out even after lock down. After all who wants to be a statistic in the next surge. I would feel much more comfortable knowing that there were some good treatments available to reduce the risk of serious complications.
slinkyj
30/4/2020
14:01
FINNCAP “We reiterate our 120p target price with the prospect that this could rise by up to 240p on a positive outcome of first data readout.” We are at 64p ffs so a 100% upside if the first target is met and 375% if the 2nd target is met.
adorling
30/4/2020
14:00
Are you feeling better today cambradjones,.. tern around hey
thwarnts
30/4/2020
13:58
75 have been dosed ie finished the treatment period of two weeksI suspect the next will be enrolled within next ten days, so last bits of data collected by 20th of May, then analyse and publish results first week of juneExtension to home use is a brilliant move, but the logistics of identifying such individuals will be difficult... Will it be candidates identified by GPs or those presenting to A&E but not deemed ill enough to be admitted (there are criteria that we use to admit to hospital... Basically low oxygen levels with the 'standard covid symptoms'Exciting timesJust upset I didn't top up today, when I planned to after yesterday's dropNever mindGLA
yet another final
30/4/2020
13:56
Agree with slinkyj, rise into the close.
cambradjones
30/4/2020
13:50
re equities , the thing is they (every gov) are throwing money at the problem and as they say , they will do everything it takes , lots of fomo kicking in too so gawd knows how high it'll bounce

sorry for the off topic

d1nga
30/4/2020
13:49
Already had an rns
bobaxe1
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older

Your Recent History

Delayed Upgrade Clock